News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
381,712 Results
Type
Article (25922)
Company Profile (59)
Press Release (355731)
Multimedia
Podcasts (25)
Webinars (7)
Section
Business (104258)
Career Advice (449)
Deals (16872)
Drug Delivery (51)
Drug Development (47594)
Employer Resources (47)
FDA (12262)
Job Trends (8440)
News (185922)
Policy (19423)
Tag
Academia (1750)
Accelerated approval (3)
Adcomms (8)
Allergies (73)
Alliances (26744)
ALS (57)
Alzheimer's disease (811)
Antibody-drug conjugate (ADC) (51)
Approvals (12326)
Artificial intelligence (170)
Autoimmune disease (10)
Automation (4)
Bankruptcy (142)
Best Places to Work (6892)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (39)
Bladder cancer (59)
Brain cancer (17)
Breast cancer (192)
Cancer (1431)
Cardiovascular disease (119)
Career advice (407)
Career pathing (13)
CAR-T (70)
Cell therapy (199)
Cervical cancer (13)
Clinical research (40513)
Collaboration (439)
Compensation (126)
Complete response letters (9)
COVID-19 (1493)
CRISPR (12)
C-suite (139)
Cystic fibrosis (42)
Data (1525)
Decentralized trials (2)
Denatured (17)
Depression (30)
Diabetes (174)
Diagnostics (3521)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (54)
Drug shortages (21)
Duchenne muscular dystrophy (55)
Earnings (36916)
Editorial (20)
Employer branding (6)
Employer resources (44)
Events (51804)
Executive appointments (447)
FDA (13250)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (402)
Gene editing (36)
Generative AI (10)
Gene therapy (126)
GLP-1 (402)
Government (3035)
Grass and pollen (3)
Guidances (42)
Healthcare (12186)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (40)
Indications (19)
Infectious disease (1563)
Inflammatory bowel disease (79)
Inflation Reduction Act (4)
Influenza (26)
Intellectual property (50)
Interviews (40)
IPO (7038)
IRA (19)
Job creations (1839)
Job search strategy (378)
Kidney cancer (7)
Labor market (10)
Layoffs (169)
Leadership (4)
Legal (3632)
Liver cancer (57)
Lung cancer (232)
Lymphoma (100)
Machine learning (3)
Management (17)
Manufacturing (104)
MASH (48)
Medical device (12906)
Medtech (12909)
Mergers & acquisitions (10123)
Metabolic disorders (432)
Multiple sclerosis (54)
NASH (11)
Neurodegenerative disease (49)
Neuropsychiatric disorders (9)
Neuroscience (1144)
NextGen: Class of 2025 (3930)
Non-profit (2822)
Now hiring (16)
Obesity (218)
Opinion (70)
Ovarian cancer (52)
Pain (64)
Pancreatic cancer (53)
Parkinson's disease (88)
Partnered (11)
Patents (112)
Patient recruitment (82)
Peanut (37)
People (34715)
Pharmaceutical (17)
Pharmacy benefit managers (11)
Phase I (11605)
Phase II (17533)
Phase III (14414)
Pipeline (686)
Policy (59)
Postmarket research (1668)
Preclinical (3615)
Press Release (18)
Prostate cancer (76)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (183)
Real estate (2846)
Recruiting (16)
Regulatory (14211)
Reports (16)
Research institute (1607)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (51)
Series A (66)
Series B (48)
Service/supplier (3)
Sickle cell disease (21)
Special edition (3)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2120)
Stomach cancer (8)
Supply chain (38)
Tariffs (11)
The Weekly (8)
Vaccines (354)
Venture capitalists (13)
Weight loss (141)
Women's health (17)
Worklife (4)
Date
Today (3)
Last 7 days (457)
Last 30 days (1356)
Last 365 days (18387)
2025 (5902)
2024 (19848)
2023 (22736)
2022 (30680)
2021 (32984)
2020 (32190)
2019 (28412)
2018 (21810)
2017 (18906)
2016 (18111)
2015 (21195)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (354)
Alabama (17)
Alaska (2)
Arizona (118)
Arkansas (10)
Asia (24550)
Australia (3887)
California (3052)
Canada (1221)
China (372)
Colorado (165)
Connecticut (172)
Delaware (115)
Europe (47925)
Florida (543)
Georgia (126)
Idaho (33)
Illinois (359)
India (14)
Indiana (223)
Iowa (3)
Japan (119)
Kansas (73)
Kentucky (12)
Louisiana (7)
Maine (27)
Maryland (634)
Massachusetts (2134)
Michigan (107)
Minnesota (270)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (33)
New Hampshire (60)
New Jersey (1125)
New Mexico (9)
New York (953)
North Carolina (554)
North Dakota (4)
Northern California (1334)
Ohio (131)
Oklahoma (3)
Oregon (23)
Pennsylvania (825)
Puerto Rico (7)
Rhode Island (24)
South America (520)
South Carolina (21)
Southern California (1171)
Tennessee (77)
Texas (538)
United States (12774)
Utah (111)
Virginia (80)
Washington D.C. (40)
Washington State (229)
West Virginia (3)
Wisconsin (42)
381,712 Results for "visby medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Visby Medical Receives Landmark FDA De Novo Authorization for First-Ever OTC PCR Test for Sexual Health
March 28, 2025
·
3 min read
Press Releases
Visby Medical™ Receives FDA Clearance and CLIA Waiver for Point-of-Care Respiratory Health Test
February 26, 2025
·
2 min read
Press Releases
Visby Medical Secures Additional $3.9M from CARB-X to Fight Antibiotic Resistance with PCR-Based Mutation Detection at the POC
January 15, 2025
·
3 min read
Biotech Bay
Visby Medical™ Receives FDA Clearance and CLIA Waiver for Second Generation Sexual Health Test for Women
Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the U.S. Food and Drug Administration for its second generation point of care (POC) test.
March 14, 2023
·
4 min read
Business
Visby Medical Appoints Everett Cunningham to Board of Directors
Visby Medical™, a leading medical diagnostic company, announced Everett Cunningham has been appointed to the company’s Board of Directors.
May 25, 2022
·
2 min read
FDA
Visby Medical™ Receives FDA Emergency Use Authorization for Respiratory Health Test for use in CLIA waived settings
Visby Medical™ announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.
January 3, 2023
·
3 min read
Biotech Bay
Visby Medical Expands Series E Round to Over $135 Million
Visby Medical™, a leading medical diagnostic company, announced that it expanded its over-subscribed Series E financing round to include an additional $35 million for a total of over $135 million raised in the round.
June 29, 2022
·
3 min read
Biotech Bay
Visby Medical Raises over $100 Million in Series E Financing
Visby Medical™, a leading medical diagnostic company, announced that it has raised over $100 million in its Series E financing round, with investment led by Ping An Voyager Partners and joined by the Healthcare of Ontario Pension Plan.
March 1, 2022
·
3 min read
Business
Visby Medical Appoints Terri S. Bresenham and Scott Edward Mendel to Board of Directors
Visby Medical, a leading medical diagnostic company, today announced Terri Bresenham and Scott Mendel have been appointed to the company’s Board of Directors.
January 4, 2022
·
3 min read
Biotech Bay
Visby Medical to Present at the J.P. Morgan 40th Annual Healthcare Conference
Visby Medical™, a leading medical diagnostic company, today announced that it will make its debut appearance at the 40th Annual J.P. Morgan Healthcare Conference.
January 10, 2022
·
1 min read
1 of 38,172
Next
